ArticleJournal of cancer research and clinical oncology2021

Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC).

Xiaoting Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.